IQVIA COA LICENSING SOLUTIONS

Frictionless access to the right COAs, at global scale

IQVIA’s Clinical Outcome Assessment (COA) Licensing Solutions are designed to remove complexity, reduce study start‑up timelines, and ensure sponsors gain compliant, timely access to the COAs required to support patient‑centric endpoints.

Solutions Research & Development Consulting Patient Centered Solutions Licensing IQVIA COAs IQVIA COA Licensing Solutions

Solving the COA licensing challenge

COAs are foundational to modern clinical development, supporting regulatory decision‑making, labeling claims, and evidence generation around patient experience, symptoms, and functioning. Yet licensing COAs is often underestimated as a source of delay and risk due to:

Fragmented author and distributor ecosystems
Unclear usage rights, translation permissions, and eCOA migration terms
Multiple versions, variants, and copyright holders
Long contracting timelines and administrative burden

IQVIA addresses these challenges with a proven, end‑to‑end COA licensing model that is scalable, compliant, and operationally efficient.

CORE COA LICENSING CAPABILITIES

COA licensing you can trust

IQVIA is your single, trusted partner from initial author outreach through licensing execution so your teams can stay focused on advancing the study. When needed, we can also act on full COA strategy and implementation.

Our solution

End‑to‑end COA licensing management

IQVIA manages the full COA licensing lifecycle on your behalf, including:

Identification and validation of the correct instrument, version, and copyright holder
Direct coordination with COA authors and distributors
Contracting and execution of license agreements
Management of usage rights, modification of COAs, amendments, renewals, and payments
Alignment of licensing terms with study timelines and operational needs

By acting as the central project management coordinator with COA owners, IQVIA eliminates administrative burden for sponsors and ensures nothing stalls your trial before first patient in.

Author relations, handled for you

Strong, established relationships with COA authors are essential to avoid delays and misalignment. IQVIA maintains long‑standing author and publisher relationships and manages all communications on your behalf—professionally, transparently, and in line with author expectations.

This approach:

Reduces back‑and‑forth and contracting friction
Ensures consistent, accurate interpretation of usage rights
Protects scientific integrity and intellectual property
Minimizes risk of non‑compliant COA use

Sponsors benefit from faster approvals, fewer escalations, and smoother collaboration across stakeholders.

End-to-end solution

Scalable implementation at global level

COA identification aligned to study objectives and endpoints

We manage licensing updates, version changes, and implementation impacts throughout the study lifecycle to maintain continuity and compliance.

Assessment of regulatory acceptance and evidentiary fit:

We evaluate each COA against regulatory guidance and precedent to support downstream submissions, labeling discussions, and payer evidence needs.

Planning support for global, multi study programs

We design scalable COA strategies that anticipate future studies, regions, and amendments, reducing rework and accelerating subsequent trials.

Gap analysis across versions, languages, and modes of administration:

We proactively assess versioning, translation availability, and administration formats to prevent late‑stage licensing, linguistic, or eCOA delays.

Linguistic Validation & eCOA migration

We orchestrate licensing, ISO‑aligned linguistic validation, and digital migration in a coordinated workflow to streamline study start‑up and execution.

Coordination across vendors & platforms

We act as a single integration layer across sponsors, authors, eCOA providers, and translation partners to reduce handoffs and operational friction.

Change management across protocol amendment

We manage licensing updates, version changes, and implementation impacts throughout the study lifecycle to maintain continuity and compliance.

Global deployment across regions and languages

We enable consistent, compliant COA deployment worldwide, supporting diverse patient populations and complex multinational study designs.

IQVIA COA Licensing Solutions

Designed to reduce time to trial

IQVIA’s COA licensing and implementation approach is built around one goal: getting studies started faster without compromising quality or compliance.

Sponsors consistently choose IQVIA to:

Ensure readiness for global and digital deployment
Prevent protocol delays caused by missing permissions
Avoid last‑minute licensing surprises
Reduce internal workload and legal review cycles

By centralizing COA activities under one experienced partner, study teams gain predictability, speed, and confidence.

Get in touch

Why sponsors chose IQVIA for COA licensing

Dedicated, specialized COA licensing teams

IQVIA provides sponsors with access to dedicated COA licensing specialists who focus exclusively on Clinical Outcome Assessments, bringing deep expertise in instrument versioning, copyright management, and clinical trial operations. This specialization ensures faster issue resolution, higher accuracy, and consistent execution across studies, reducing the operational risk often associated with COA licensing.

Established relationships with COA authors and distributors

IQVIA maintains long‑standing, trusted relationships with COA authors, publishers, and distributors worldwide, enabling efficient communication, faster approvals, and smoother negotiations. These established author relations help sponsors avoid common delays, misinterpretations of usage rights, and last‑minute licensing challenges that can impact study timelines

Scalable processes from early phase to large global programs

IQVIA’s COA licensing model is designed to scale seamlessly from early‑phase trials to complex, multinational programs, supporting multiple studies, regions, and languages. Standardized processes, tools, and governance ensure consistency and compliance while allowing flexibility to adapt to evolving protocol and portfolio needs

Optional end-to-end COA planning & implementation

Beyond licensing, IQVIA offers optional end‑to‑end COA & eCOA services, including selection, planning, linguistic validation, and global implementation, creating a single, integrated operating model. This approach minimizes vendor handoffs, simplifies oversight, and enables sponsors to fully outsource COA activities when speed, consistency, and risk reduction are critical.

Seamless integration with broader patient-centric and eCOA services

IQVIA’s COA licensing solutions integrate seamlessly with its broader patient‑centric, eCOA, and clinical technologies ecosystem, enabling coordinated delivery across data collection, translation, and digital deployment. This integration supports higher data quality, improved patient experience, and accelerated time to trial by aligning COA activities with the broader clinical development strategy.

Contact our experts

Get started

Whether you need support with a single COA license or a fully managed, global COA strategy, IQVIA is ready to help. Contact us to discuss your COA licensing needs and learn how we can simplify your path to trial start.